Skip to main content
BIO CEO & Investor Conference Logo

February 26-27, 2024・New York, NY

BIO CEO & Investor Conference Logo

February 26-27, 2024・New York, NY

Schedule at a Glance

blue gradient

Loading
7:00 AM
  1. Networking Breakfast
  2. Registration Open
8:00 AM
  1. BIO One-on-One Partnering Meetings
9:00 AM
  1. Company Presentations
  2. Panel Sessions & Fireside Chats
10:00 AM
  1. Panel Sessions & Fireside Chats
11:00 AM
  1. Panel Sessions & Fireside Chats
12:00 PM
  1. Networking Lunch
1:00 PM
  1. Panel Sessions & Fireside Chats
1:15 PM
  1. Company Presentations
2:00 PM
  1. Panel Sessions & Fireside Chats
3:00 PM
  1. Panel Sessions & Fireside Chats
4:00 PM
  1. Panel Sessions & Fireside Chats
6:00 PM
  1. Welcome Reception
6:30 AM
  1. Registration Open
  2. Networking Breakfast
7:00 AM
  1. BIO One-on-One Partnering Meetings
9:00 AM
  1. Panel Sessions & Fireside Chats
  2. Company Presentations
10:00 AM
  1. Panel Sessions & Fireside Chats
11:00 AM
  1. Panel Sessions & Fireside Chats
12:00 PM
  1. Networking Lunch
1:00 PM
  1. Panel Sessions & Fireside Chats
1:15 PM
  1. Company Presentations
2:00 PM
  1. Panel Sessions & Fireside Chats
3:00 PM
  1. Panel Sessions & Fireside Chats
Testimonials
  • It's the kind of meeting where biotech newsmakers can have productive dialogs with investors and other key players.
    Luke Timmerman
    The Timmerman Report
  • It's the caliber of attendees - biopharma companies on the verge of their next big step and investors looking for smart opportunities - that make BIO CEO & Investor Conference vital to the industry.
    Anna Kazanchyan, M.D.
    CEO & Chairwoman, Saghmos Therapeutics
  • The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem.
    Phillip Ross
    Global Chairman J.P. Morgan Healthcase Investment Banking
  • The BIO CEO & Investor Conference provides timely and relevant content on the issues driving the business of biotech, along with an invaluable platform for networking and partnering.
    Chris Garabedian
    CEO, Xontogency and Portfolio Manager, PXV Fund
Search